Advertisement

Topics

NeuroPace Announces 1,000th Patient Treated with RNS® System for Medically Refractory Epilepsy

09:00 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
NeuroPace, Inc. announced today that the 1000th patient has been treated with its award-winning RNS® System, approved by the FDA in November 2013. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS ...

Other Sources for this Article

MSLGROUP
Hillary Marder, 202-683-3130

NEXT ARTICLE

More From BioPortfolio on "NeuroPace Announces 1,000th Patient Treated with RNS® System for Medically Refractory Epilepsy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...